Product Program year 2025 Source: CMS Open Payments

Vafseo

Drug Nephrology

NDC 59922-642-60

Open in the dashboard

General payments

$1,699,995

12,334 payments

Research payments

$6,456,177

1,638 payments

Through program year 2025, $1,699,995 in general payments and $6,456,177 in research payments were reported against Vafseo (Nephrology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2025 General $1,410,441 7,966
2025 Research $5,277,515 1,637
2024 General $289,555 4,368
2024 Research $1,178,662 1

Breakdown

Who paid General payments · program years 2024–2025
  1. Akebia Therapeutics Inc $1,699,995 12,334 payments
Top recipients General payments · program year 2025
  1. Ashte Collins Nephrology · Washington, DC $98,891 7% · 295 payments
  2. Glenn Chertow Nephrology · Stanford, CA $89,878 6% · 13 payments
  3. Luis Alvarez Nephrology · Palo Alto, CA $56,677 4% · 95 payments
  4. Nimish Naik Nephrology · Wexford, PA $50,014 4% · 149 payments
  5. Ramon Mendez Nephrology · Woodbridge, VA $48,784 3% · 122 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Nephrology Internal Medicine $1,253,281 91% · 1,638 practitioners
  2. Nurse Practitioner, Adult Health Nurse Practitioner $32,326 2% · 49 practitioners
  3. Nurse Practitioner, Family Nurse Practitioner $31,019 2% · 296 practitioners
  4. Nurse Practitioner $23,396 2% · 198 practitioners
  5. Internal Medicine $10,215 <1% · 130 practitioners

The top 5 of 52 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. California $341,472 24% · 410 recipients
  2. Texas $134,673 10% · 238 recipients
  3. Georgia $111,860 8% · 128 recipients
  4. Florida $108,198 8% · 213 recipients
  5. Maryland $102,124 7% · 53 recipients

The top 5 of 49 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

12,334 general · 1,638 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record